KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Assets Average (2016 - 2025)

Historic Assets Average for Bristol Myers Squibb (BMY) over the last 16 years, with Q4 2025 value amounting to $93.5 billion.

  • Bristol Myers Squibb's Assets Average rose 35.11% to $93.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $93.5 billion, marking a year-over-year increase of 35.11%. This contributed to the annual value of $91.3 billion for FY2025, which is 272.74% down from last year.
  • Bristol Myers Squibb's Assets Average amounted to $93.5 billion in Q4 2025, which was up 35.11% from $95.8 billion recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Assets Average high stood at $115.5 billion for Q1 2021, and its period low was $92.4 billion during Q3 2023.
  • Its 5-year average for Assets Average is $99.2 billion, with a median of $96.3 billion in 2024.
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 1326.11% in 2021, then soared by 314.59% in 2024.
  • Bristol Myers Squibb's Assets Average (Quarter) stood at $110.1 billion in 2021, then fell by 11.44% to $97.5 billion in 2022, then fell by 4.41% to $93.2 billion in 2023, then decreased by 0.08% to $93.1 billion in 2024, then increased by 0.35% to $93.5 billion in 2025.
  • Its Assets Average was $93.5 billion in Q4 2025, compared to $95.8 billion in Q3 2025 and $93.6 billion in Q2 2025.